Reproductive Techniques, Assisted

• 

  Subject Areas on Research

  • Acupuncture as adjunctive therapy in assisted reproduction: remaining uncertainties. 
  • Antenatal paternal adjustment and paternal attitudes after infertility treatment. 
  • Assisted reproductive technology and association with childhood cancer subtypes. 
  • Clinical pregnancy (CP) and live birth (LB) increase significantly with each additional fertilized oocyte up to nine, and CP and LB decline after that: an analysis of 15,803 first fresh in vitro fertilization cycles from the Society for Assisted Reproductive Technology registry. 
  • Clinical pregnancy and live birth increase significantly with every additional blastocyst up to five and decline after that: an analysis of 16,666 first fresh single-blastocyst transfers from the Society for Assisted Reproductive Technology registry. 
  • Clomifene and Assisted Reproductive Technology in Humans Are Associated with Sex-Specific Offspring Epigenetic Alterations in Imprinted Control Regions. 
  • Contributions of infertility treatment to very-low-birth-weight multiple birth infants receiving neonatal intensive care. 
  • Development. The minimalist Y. 
  • Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. 
  • Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry. 
  • Effectiveness of assisted reproductive technology (ART). 
  • Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility. 
  • Evidence-Based Care for Couples With Infertility. 
  • Fertility drugs and the risk of breast cancer: a meta-analysis and review. 
  • Fertility treatment is associated with multiple meningiomas and younger age at diagnosis. 
  • Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion. 
  • Gender inequality in leadership and academic rank in academic reproductive endocrinology programs. 
  • Increased Risk of Aortic Dissection Associated With Pregnancy in Women With Turner Syndrome: A Systematic Review. 
  • Innovations in infertility: a comprehensive analysis of the ClinicalTrials.gov database. 
  • Insurance mandates and trends in infertility treatments. 
  • Insurance mandates, embryo transfer, outcomes--the link is tenuous. 
  • Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial. 
  • Is it time to establish age restrictions in ART? 
  • Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites. 
  • Medical study: aspiring parents, genotypes and phenotypes: the unexamined myth of the perfect baby. 
  • Obstetrician-gynecologists' beliefs about assisted reproductive technologies. 
  • Organophosphate flame-retardant metabolite concentrations and pregnancy loss among women conceiving with assisted reproductive technology. 
  • Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis. 
  • Ovarian hyperstimulation syndrome: A review for emergency clinicians. 
  • Perspectives: the possible influence of assisted reproductive technologies on transgenerational reproductive effects of environmental endocrine disruptors. 
  • Pre-implantation genetic testing alters the sex ratio: an analysis of 91,805 embryo transfer cycles. 
  • Preconceptional considerations and counseling for the infertile couple. 
  • Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. 
  • Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. 
  • Progesterone and the luteal phase: a requisite to reproduction. 
  • Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. 
  • Redefining the relationship between sperm deoxyribonucleic acid fragmentation as measured by the sperm chromatin structure assay and outcomes of assisted reproductive techniques. 
  • Reexpressing Parenthood 
  • Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique outcomes. 
  • Retrospective. Anne McLaren (1927-2007). 
  • Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk? 
  • The Risk of Congenital Anomalies by Fertility Treatment Modality. 
  • The effects of competition on assisted reproductive technology outcomes. 
  • Third-party reproduction in the Internet Age: the new, patient-centered landscape. 
  • Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer. 
  • Trends in Infertility Care Among Commercially Insured US Women During the COVID-19 Pandemic. 
  • Who pays? Mandated insurance coverage for assisted reproductive technology.